Scientists are set to test gene-edited pig livers as a temporary treatment for sudden liver failure, allowing patients' own livers to rest and potentially heal. The FDA has approved this unique clinical trial by eGenesis and OrganOx, aiming to address the high mortality rates associated with liver disease. The study will involve attaching a pig liver externally to patients who do not qualify for transplants, with hopes of supporting liver functions for a few days. Teljes cikk (Euronews.com)